Company news

Avecho Biotechnology Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Phosphagenics Initiates Cattle Study

June 1, 2016

Phosphagenics Expands Licence Agreement for Diclofenac Gel

May 18, 2016

Phosphagenics Expands Japanese Option to Oxycodone Patch

May 17, 2016

Phosphagenics Signs Japanese License Option and R&D Alliance

April 29, 2016

Successful Results -Phase 2 TPM Trentinoin Gel Study on Acne

March 30, 2016

Response to an ASX Price Query

March 30, 2016

Positive Results Phase 1B Study Transdermal Oxycodone Patch

March 30, 2016

POH Global Agreement with Novartis Animal Health

March 30, 2016

Phosphagenics Launches Australian Skincare Products

March 30, 2016

June 2010 Half Yearly Appendix 4D and Financial Report

March 30, 2016

December 2009 Appendix 4E and Statutory Financial Report

March 30, 2016

Appointment of Joint CEO - Dr Esra Ogru

March 30, 2016

Trading halt

March 30, 2016

Preparation- pain patch manufacturing after positive results

March 30, 2016

POH Ready to Commence Pivital Oxycodone Clinical Trials

March 30, 2016

POH: Phosphagenics - Calzada - Exercise of option

March 30, 2016

POH: Anti-fat Peptide Patch progresses

March 30, 2016

Phosphagenics to Partner Agricultural Company for ANZ market

March 30, 2016

Phosphagenics moves into lucrative hair market

March 30, 2016

Phosphagenics collaboration to develop psoriasis drug

March 30, 2016

Phosphagenics Collaborates With 3M To Develop Pain Patch

March 30, 2016

New National Stockist for ELIXIA Personal Care Product Range

March 30, 2016

Major Distribution Agreement for Asia for ELIXIA Products

March 30, 2016

Launch of BodyShaper Cellulite Contour Creme

March 30, 2016

June 2011 Half Yearly Appendix 4D and Financial Report

March 30, 2016

Equity Raising

March 30, 2016

Elixia range of Personal Care Products - Update

March 30, 2016

Appendix 4E December 2010 Preliminary Final Report

March 30, 2016

Successful $24.1m Capital Raising and $3m SPP

March 30, 2016

POH Signs License Agreement with Intas Pharmaceuticals

March 30, 2016

POH Further Refinements to Oxycodone Patch Design

March 30, 2016

POH adds David Jones as retail partner for Elixia products

March 30, 2016

Pivotal TPM-oxycodone Patch Trials Begin

March 30, 2016

Neura Therapeutik Appointed as US Strategic Advisors

March 30, 2016

Korean Distribution Agreement for BioElixia

March 30, 2016

December 2011 Preliminary Final and Audited Financial Report

March 30, 2016

TPM/Diclofenac Gel - Themis in Supply Agmt with Novartis

March 30, 2016

POH signs Agreement with Agricultural Research Service

March 30, 2016

POH Licences TPM Platform to Indian Pharmaceutical Company

March 30, 2016

POH in JV to Supply TPM Equine Supplements to Golbal Market

March 30, 2016

Phosphagenics to Supply Firming Cream to GNC

March 30, 2016

Phosphagenics Pain Program Update

March 30, 2016

Oxymorphone Patch Meets Phase 1 End Points

March 30, 2016

Oxycodone Patch Update - Development and Product Expansion

March 30, 2016

Oxycodone Patch Update

March 30, 2016

Invoicing and Accounting Misappropriations Investigation

March 30, 2016

Invoicing and Accounting Irregularities

March 30, 2016

December 2012 Appendix 4E and Audited Financial Report

March 30, 2016

POH Topical Oxycodone Patch Alleviates Pain in Racehorses

March 30, 2016

Phosphagenics - TPM in Dairy Feed Inclusion Technology

March 30, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 23 decks. Every deck is listed under its year.